Purdue Pharma offers $10-12 billion to settle opioid claims

Brasil Notícia Notícia

Purdue Pharma offers $10-12 billion to settle opioid claims
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 MSNBC
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Purdue Pharma and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10B to $12B, according to 2 people familiar with the mediation.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

MSNBC /  🏆 469. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

It Is Too Early for Pharma Investors to Cheer Opioid VerdictIt Is Too Early for Pharma Investors to Cheer Opioid VerdictHold the celebration: The opioid litigation cloud hanging over drug stocks won’t clear up soon, despite an Oklahoma judge’s ruling that Johnson & Johnson is liable for fueling the opioid crisis.
Consulte Mais informação »

Shares of pharma companies soar after Johnson & Johnson sees smaller-than-expected opioid fineShares of pharma companies soar after Johnson & Johnson sees smaller-than-expected opioid fineShares of major pharmaceutical companies surged in after-hours trading Monday following a smaller-than-expected fine for Johnson & Johnson.
Consulte Mais informação »

Shares of pharma companies soar after Johnson & Johnson sees smaller-than-expected opioid fineShares of pharma companies soar after Johnson & Johnson sees smaller-than-expected opioid fineShares of major pharmaceutical companies surged in after-hours trading Monday following a smaller-than-expected fine for Johnson & Johnson.
Consulte Mais informação »

It Is Too Early for Pharma Investors to Cheer Opioid VerdictIt Is Too Early for Pharma Investors to Cheer Opioid VerdictHold the celebration: The opioid litigation cloud hanging over drug stocks won’t clear up soon, despite an Oklahoma judge’s ruling that Johnson & Johnson is liable for fueling the opioid crisis.
Consulte Mais informação »



Render Time: 2025-03-05 21:30:25